Revvity Signals - Drug Discovery

Seed Group and Dante Genomics Form Strategic Partnership to Drive Scientific Advancements in the MENA Region

Tuesday, June 20, 2023

Dante Genomics and Seed Group have formed a strategic partnership to bring innovative genomics and precision medicine solutions to the MENA region. Dante Genomics, a global leader in the field, specializes in personalized healthcare and has developed customized genomic analysis processes that significantly impact people's lives. Operating in 97 countries, the company aims to accelerate scientific advancements.

As part of the partnership, Seed Group will support Dante Genomics in introducing their technology and innovations to the UAE and the broader region. Leveraging its expertise and network, Seed Group will assist Dante Genomics in reaching the appropriate audience, connecting with key decision-makers in the government and private sectors, and contributing to the integration of the latest technological innovations in healthcare.

Hisham Al Gurg, CEO of Seed Group and the Private Office of Sheikh Saeed bin Ahmed Al Maktoum, believes that genetics and genome sequencing are the future of healthcare. With the UAE's visionary leadership, advanced infrastructure, and commitment to innovation, the country is well-positioned for healthcare transformation. The partnership with Dante Genomics is expected to drive healthcare advancements, establishing the UAE as a global leader in genomics and personalized medicine.

Andrea Riposati, co-founder and CEO of Dante Genomics, emphasizes Dubai's prominence as an investment hub for precision medicine. Dante Genomics' clinical sequencing center in Dubai serves as a global hub for delivering top-quality precision medicine. The partnership with Seed Group further strengthens the availability of these genomic solutions.

Dante Genomics utilizes genome sequencing technology and interpretation, leveraging proprietary genomic platforms powered by artificial intelligence and machine learning. These platforms integrate and optimize resources and information, fostering synergies among all stakeholders. The company also collaborates with international associations and advocacy groups to develop solutions that enhance patients' quality of life.

Recognized for their achievements, the founders of Dante Genomics received the EY award for "Best Entrepreneurs of the Year" in 2019. Additionally, the company was ranked sixth in the 2023 growth leaders list compiled by Statista and Il Sole 24 Ore.

Seed Group, known for its expertise in the technology, healthcare, hospitality, and telecommunications sectors in the Middle East, has successfully formed strategic alliances with leading global companies over the past 16 years. These alliances have facilitated sustainable market entry and growth within the Gulf Cooperation Council countries.